Nichi-Iko will convert the formulation of 'Limaprost Alfadex tablets 5 -microg (Nichiiko)', currently manufactured and marketed by Nichi-Iko, to a formulation which has been improved for moisture resistance stability following the technology transfer based on patents owned by ONO. After receiving an approval for this improved formulation change, for a partial change in approved items of the manufacturing and marketing approval, Nichi-Iko will manufacture and market the improved formulation in bulk packaging standards through this technical collaboration.
Ono will continue to manufacture and market Opalmon Tablet 5 -microg.
Contact:
Tel: +81-(0)76-442-7026
(C) 2020 Electronic News Publishing, source